N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

McCallum, Matthew, De Marco, Anna, Lempp, Florian A., Tortorici, M. Alejandra, Pinto, Dora, Walls, Alexandra C., Beltramello, Martina, Chen, Alex +26 more·2021·Cell
DOI 10.1016/j.cell.2021.03.028

Cited by (909)

Items 501–600 of 909

  1. SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
    Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, Meike Dittmann · 2021 · Microorganisms
  2. Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking
    Lihong Liu, Ryan G. Casner, Yicheng Guo, Qian Wang, Sho Iketani, Jasper Fuk‐Woo Chan, Jian Yu, Bernadeta Dadonaite, Manoj S. Nair, Hiroshi Mohri et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Structural Analysis of Spike Protein Mutations in the SARS-CoV-2 P.3 Variant
    Bascos, Neil Andrew D., Mirano-Bascos, Denise, Saloma, Cynthia P. · 2021
  4. Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1
    Jialu Shi, Xiaoyu Zhao, Xiaohui Jin, Jiayan Li, Yuanchen Liu, Huan Liu, Ye‐Fan Hu, Zhe Chen, Yuxin Xiao, Lei Wang et al. · 2025 · Nature Communications
  5. The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint
    Hua Guo, Ang Li, Haofeng Lin, Meiqin Liu, Jing Chen, Tingting Jiang, Bei Li, Yi Wang, Michael C. Letko, Wenjie Peng et al. · 2022 · Journal of Virology
  6. A systematic review on impact of SARS-CoV-2 infection
    Thirumugam Gowripriya, Yashwanth Radhakrishnan, Suresh Ramamurthi, James Prabhanand Bhaskar, Krishnaswamy Balamurugan · 2023 · Microbiological Research
  7. Potent NTD-Targeting Neutralizing Antibodies against SARS-CoV-2 Selected from a Synthetic Immune System
    Wenping Li, Fulian Wang, Yu Li, Lei Yan, Lili Liu, Wei Zhu, Peixiang Ma, Xiaojie Shi, Guang Yang · 2023 · Vaccines
  8. Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses
    Fusheng Si, Ruisong Yu, Shijuan Dong, Bingqing Chen, Chunhua Li, Shuai Song · 2024 · Vaccines
  9. Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines
    Charlotte Dubé, Sarah Paris‐Robidas, Guadalupe Andreani, Cindy Gutzeit, Marc‐André D’Aoust, Brian J. Ward, Sonia Trépanier · 2022 · Vaccine
  10. Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
    Marianne Graninger, Jeremy Vann Camp, Stephan Walter Aberle, Marianna Theresia Traugott, Wolfgang Hoepler, Elisabeth Puchhammer‐Stöckl, Lukas Weseslindtner, Alexander Zoufaly, Judith Helene Aberle, Karin Stiasny · 2022 · Frontiers in Immunology
  11. Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
    Jiangchao Xiang, Jie Su, Qiaoshuai Lan, Wenwen Zhao, Yu Zhou, Youwei Xu, Jun Niu, Shuai Xia, Qilian Qi, Sachdev S. Sidhu et al. · 2022 · Communications Biology
  12. Omicron infection increases IgG binding to spike protein of predecessor variants
    Gokulnath Mahalingam, Yogapriya Periyasami, Porkizhi Arjunan, Rajesh Kumar Subaschandrabose, Tamil Venthan Mathivanan, Roshlin S. Mathew, Ramya Devi, Prasanna S. Premkumar, Jayaprakash Muliyil, Alok Srivastava et al. · 2022 · Journal of Medical Virology
  13. ACE2 receptor polymorphism in humans and animals increases the risk of the emergence of SARS-CoV-2 variants during repeated intra- and inter-species host-switching of the virus
    Christian Albert Devaux, Jacques Fantini · 2023 · Frontiers in Microbiology
  14. Exploring Conformational Landscapes and Cryptic Binding Pockets in Distinct Functional States of the SARS-CoV-2 Omicron BA.1 and BA.2 Trimers: Mutation-Induced Modulation of Protein Dynamics and Network-Guided Prediction of Variant-Specific Allosteric Binding Sites
    Gennady M. Verkhivker, Mohammed Alshahrani, Grace Gupta · 2023 · Viruses
  15. The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant
    Cassandra L. Pegg, N. Modhiran, Rhys Harold Parry, Benjamin Liang, A. Amarilla, A. Khromykh, L. Burr, Paul R. Young, K. Chappell, B. Schulz et al. · 2023 · bioRxiv
  16. SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations
    Gila Lustig, Yashica Ganga, Hylton E. Rodel, Houriiyah Tegally, Afrah Khairallah, Laurelle Jackson, Sandile Cele, Khadija Khan, Zesuliwe Jule, Kajal Reedoy et al. · 2023 · Virus Evolution
  17. A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
    Rong Zhang, Dedong Li, Kun Xu, Chenxi Yang, Tingrong Luo, Xin Zhao, George F Gao · 2021 · The Lancet Microbe
  18. SARS-CoV-2 gained a novel spike protein S1–N-Terminal Domain (S1-NTD)
    Perumal Arumugam Desingu, K. Nagarajan, Kuldeep Dhama · 2022 · Environmental Research
  19. IS IT TIME TO REFLECT, NOT ON THE “WHAT” BUT THE “WHY” IN EMERGING WILDLIFE DISEASE RESEARCH?
    Richard Anthony Kock · 2018 · Journal of Wildlife Diseases
  20. An anti-SARS-CoV-2 non-neutralizing antibody with Fc-effector function defines a new NTD epitope and delays neuroinvasion and death in K18-hACE2 mice
    G. Beaudoin-Bussières, Yao-Zong Chen, Irfan Ullah, Jérémie Prévost, W. Tolbert, K. Symmes, Shi-Lei Ding, M. Benlarbi, S. Gong, A. Tauzin et al. · 2021 · bioRxiv
  21. Evolving spike-protein N -glycosylation in SARS-CoV-2 variants
    Sabyasachi Baboo, Jolene K. Diedrich, Jonathan L. Torres, Jeffrey Copps, Bhavya Singh, Patrick T. Garrett, Andrew B. Ward, James C. Paulson, John R. Yates · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization
    Concetta Ragone, Angela Mauriello, Beatrice Cavalluzzo, Ernesta Cavalcanti, Luigi Russo, Carmen Manolio, Simona Mangano, Biancamaria Cembrola, Maria Tagliamonte, Luigi Buonaguro · 2024 · Frontiers in Immunology
  23. Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses
    Megi Rexhepaj, Daniel E. Asarnow, Lisa Perruzza, Young‐Jun Park, Barbara Guarino, Mathew Mccallum, Katja Culap, Christian Saliba, Giada Leoni, Alessio Balmelli et al. · 2024 · Immunity
  24. SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals
    Bernadeta Dadonaite, Allison R Burrell, Jenni Logue, Helen Y. Chu, Daniel C. Payne, David B Haslam, Mary Allen Staat, Jesse D. Bloom · 2025 · Journal of Virology
  25. Longitudinal waning of mRNA vaccine-induced neutralizing antibodies against SARS-CoV-2 detected by an LFIA rapid test
    Qiao Wang, Lili Feng, Haohai Zhang, Juehua Gao, Changchuin Mao, Esther Landesman‐Bollag, Gustavo Mostoslavsky, Justin Mark Lunderberg, Weina Zheng, Shushun Hao et al. · 2022 · Antibody Therapeutics
  26. Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
    Nell Saunders, Delphine Planas, William Bolland, Christophe Rodriguez, Slim Fourati, Julian Buchrieser, Cyril Planchais, Matthieu Prot, Isabelle Staropoli, Florence Guivel‐Benhassine et al. · 2022 · EBioMedicine
  27. Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants
    Marianna Agudelo, Frauke Muecksch, Dennis J. Schaefer-Babajew, Alice Cho, Justin DaSilva, Eva Bednarski, Victor A. Ramos, T. Oliveira, M. Cipolla, A. Gazumyan et al. · 2022 · Journal of Experimental Medicine
  28. On the Evolutionary Trajectory of SARS-CoV-2: Host Immunity as a Driver of Adaptation in RNA Viruses
    Jacob Warger, Silvana Gaudieri · 2022 · Viruses
  29. The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution
    Claudia Veneziano, Nadia Marascio, Carmela De Marco, Barbara Quaresima, Flavia Biamonte, Enrico Maria Trecarichi, Gianluca Santamaria, Angela Quirino, Daniele Torella, Aldo Quattrone et al. · 2023 · Viruses
  30. Towards Quantum-Chemical Level Calculations of SARS-CoV-2 Spike Protein Variants of Concern by First Principles Density Functional Theory
    W. Y. Ching, Puja Adhikari, Bahaa Jawad, Rudolf Podgornik · 2023 · Biomedicines
  31. HaploCoV: unsupervised classification and rapid detection of novel emerging variants of SARS-CoV-2
    Matteo Chiara, David Stephen Horner, Erika Ferrandi, Carmela Gissi, Graziano Pesole · 2023 · Communications Biology
  32. Challenges of SARS-CoV-2 genomic surveillance in India during low positivity rate scenario
    Siddharth Singh Tomar, Krishna Khairnar · 2023 · Frontiers in Public Health
  33. Cryo-EM and cryo-ET of the spike, virion, and antibody neutralization of SARS-CoV-2 and VOCs
    Cong Xu, Wenyu Han, Yao Cong · 2023 · Current Opinion in Structural Biology
  34. Shortening Epitopes to Survive: The Case of SARS-CoV-2 Lambda Variant
    Stefano Pascarella, Massimo Ciccozzi, Martina Bianchi, Domenico Benvenuto, Marta Giovanetti, Roberto Cauda, Antonio Cassone · 2021 · Biomolecules
  35. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals
    Li Min, Jiaojiao Liu, Renfei Lu, Yuchao Zhang, Meng Du, Man Xing, Zhenchuan Wu, Xiangyin Kong, Yufei Zhu, Xianchao Zhou et al. · 2022 · Journal of Allergy and Clinical Immunology
  36. Investigation of the binding and dynamic features of A.30 variant revealed higher binding of RBD for hACE2 and escapes the neutralizing antibody: A molecular simulation approach
    Athar Shafiq, Farrukh Zubair, Amna Ambreen, Muhammad Suleman, Qudsia Yousafi, Zahid Rasul Niazi, Zeeshan Anwar, Abbas Saleem Khan, Anwar Mohammad, Dongqing Wei · 2022 · Comput. Biol. Medicine
  37. Structural topological analysis of spike proteins of SARS-CoV-2 variants of concern highlight distinctive amino acid substitution patterns
    Filips Peisahovics, Mohammed A. Rohaim, Muhammad Munir · 2022 · European Journal of Cell Biology
  38. Early detection of emerging SARS-CoV-2 variants of interest for experimental evaluation
    Zachary S. Wallace, James J. Davis, Anna Maria Niewiadomska, Robert Olson, Maulik P. Shukla, Rick L. Stevens, Yun Zhang, Christian M. Zmasek, Richard H. Scheuermann · 2022 · Frontiers in Bioinformatics
  39. Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients
    Martina Brandolini, Giulia Gatti, Laura Grumiro, Silvia Zannoli, Valentina Arfilli, Monica Cricca, Giorgio Dirani, Agnese Denicolò, Maria Michela Marino, Martina Manera et al. · 2023 · Microorganisms
  40. RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2
    Hernan Hermes Monteiro da Costa, Diego J. B. Orts, Andrew D. Moura, Amaro Nunes Duarte‐Neto, Cinthya dos Santos Cirqueira, Rodrigo Albergaria Réssio, Cristina Takami Kanamura, Karen Miguita, Jerenice Esdras Ferreira, Raimunda Telma de Macêdo Santos et al. · 2023 · Viruses
  41. COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years
    Krishna Khairnar, Siddharth Singh Tomar · 2024 · Virus Research
  42. Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
    Hyeseong Cho, K. K. Gonzales-Wartz, De-Li Huang, M. Yuan, M. Peterson, Janie Y. Liang, N. Beutler, J. Torres, Yu Cong, E. Postnikova et al. · 2021 · bioRxiv
  43. Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine
    Charles C. Reed, Katherine Schultheis, Viviane M. Andrade, Richa Kalia, Jared Tur, Blake Schouest, Dustin Elwood, Jewell N. Walters, Igor Maricic, Arthur Doan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates
    Kizzmekia S. Corbett, Anne P. Werner, Sarah O’ Connell, Matthew Gagné, Lilin Lai, Juan I. Moliva, Barbara J. Flynn, Angela Choi, Matthew J. Koch, Kathryn E. Foulds et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Neutralization of recombinant RBD-subunit vaccine ZF2001-elicited antisera to SARS-CoV-2 variants including Delta
    Xin Zhao, Anqi Zheng, Dedong Li, Rong Zhang, Huan Sun, Qihui Wang, George F. Gao, Pengcheng Han, Lianpan Dai · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Insertions in the SARS-CoV-2 Spike N-Terminal Domain May Aid COVID-19 Transmission
    Su Datt Lam, Vaishali Waman, Christine Anne Orengo, Jonathan Gill Lees · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections
    Zuowei Wang, Ling Li, Ruiping Du, Xixian Chen, Yi Sun, Rongrong Qin, Yunjian Li, Hualong Feng, Lin Hu, Xuanyi Chen et al. · 2024 · iScience
  48. Intra-host SARS-CoV-2 diversity in immunocompromised people living with HIV provides insight into the evolutionary trajectory of SARS-CoV-2
    Rageema Joseph, Gert J.K. Marais, Arash Iranzadeh, Arghavan Alisoltani, Diana Ruth Hardie, Mary‐Ann Davies, Alexa Heekes, N. Chetty, Venessa Timmerman, Marvin Hsiao et al. · 2025 · Journal of Virology
  49. Identification and genomic characterization of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa
    Graeme Dor, Dikeledi Kekana, Ryan Hisner, Darren Patrick Martin, Bette Korber, Timo Ernst, Avram Levy, David John Speers, Stuart Grant Turville, Vitali Sintchenko et al. · 2026 · Virus Evolution
  50. Rise and Fall of SARS-CoV-2 Lineage A.27 in Germany
    Sébastien Calvignac‐Spencer, Matthias Budt, Matthew R. Huska, Hugues Richard, Luca Leipold, Linus Grabenhenrich, Torsten Semmler, Max von Kleist, Stefan Kröger, Thorsten Wolff et al. · 2021 · Viruses
  51. A comprehensive evolutionary and epidemiological characterization of insertion and deletion mutations in SARS-CoV-2 genomes
    Xue Liu, Liping Guo, Tiefeng Xu, Xiaoyu Lu, Mingpeng Ma, Wenyu Sheng, Yinxia Wu, Hong Peng, Liu Cao, Fuxiang Zheng et al. · 2021 · Virus Evolution
  52. Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals
    Susan L. Uprichard, Amornrat O’Brien, Monika Evdokimova, Cynthia L. Rowe, Cara Joyce, Matthew Hackbart, Yazmin E. Cruz-Pulido, Courtney A. Cohen, Michelle L. Rock, John M. Dye et al. · 2022 · Viruses
  53. Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout
    Sabine Lichtenegger, Sabine Saiger, Melina Hardt, Susanne Kulnik, Gabriel E. Wagner, Barbara Kleinhappl, Karoline Assig, Andrea Zauner, Michelle Ober, Janine Kimpel et al. · 2022 · Journal of Clinical Microbiology
  54. Humoral and cellular immunity against diverse SARS-CoV-2 variants
    Changxu Chen, Xin Wang, Zeli Zhang · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
  55. Computational Study of Potential Galectin-3 Inhibitors in the Treatment of COVID-19
    Maral Aminpour, Marco Cannariato, Angelica Zucco, Elisabetta Di Gregorio, S.L. Israel, Annalisa Perioli, Davide Tucci, Francesca Rossi, Sara Pionato, Silvia Marino et al. · 2021 · Biomedicines
  56. Analysis of the Neutralizing Activity of Antibodies Targeting Open or Closed SARS-CoV-2 Spike Protein Conformations
    Gabriel Cia, Fabrizio Pucci, Marianne J. Rooman · 2022 · International Journal of Molecular Sciences
  57. Multifaceted membrane binding head of the SARS-CoV-2 spike protein
    Anh Tran, Troy A. Kervin, Michael Overduin · 2022 · Current Research in Structural Biology
  58. A flow cytometry-based neutralization assay for simultaneous evaluation of blocking antibodies against SARS-CoV-2 variants
    Leire Egia‐Mendikute, Alexandre Bosch, Endika Prieto‐Fernández, Laura Vila-Vecilla, Samanta Romina Zanetti, So Young Lee, Borja Jiménez-Lasheras, Ana García-del Río, Asier Antoñana-Vildosola, Ander de Blas et al. · 2022 · Frontiers in Immunology
  59. COVID-19: Attacks Immune Cells and Interferences With Antigen Presentation Through MHC-Like Decoy System
    Wenzhong Liu, Li hualan · 2023 · Journal of Immunotherapy
  60. Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
    Lu Zhang, Alexandra Dopfer‐Jablonka, Inga Nehlmeier, Amy Madeleine Kempf, Luise Graichen, Noemí Calderón Hampel, Anne Cossmann, Metodi V. Stankov, Gema Morillas Ramos, Sebastian R. Schulz et al. · 2024 · Vaccines
  61. Acute Actions of Natriuretic Peptides in Coronary Vasculature and Ischaemic Myocardium
    Yohann Rautureau, Gary F. Baxter · 2004 · Current Pharmaceutical Design
  62. Stimulation of progesterone production in human granulosa-lutein cells by lipoproteins: evidence for cholesterol-independent actions of high-density lipoproteins
    Jennifer Ragoobir, D.R.E. Abayasekara, K. Richard Bruckdorfer, Anthony E. Michael · 2002 · Journal of Endocrinology
  63. A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19
    Daohong Zhang, Deepak Kukkar, Ki‐Hyun Kim, Poornima Bhatt · 2024 · International Journal of Biological Macromolecules
  64. Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection
    Kahlio Mader, Lynn B. Dustin · 2024 · Antibodies
  65. Defining the features and structure of neutralizing antibody targeting the silent face of the SARS‐CoV‐2 spike N‐terminal domain
    Zhaoyong Zhang, Yuanyuan Zhang, Yuting Zhang, Linling Cheng, Lu Zhang, Qihong Yan, Xuesong Liu, Jiantao Chen, Jun Dai, Yingying Guo et al. · 2024 · MedComm
  66. SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization
    Enya Qing, Julisa Salgado, Alexandria Wilcox, Tom Gallagher · 2024 · PLoS Pathogens
  67. A Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARS ‐ CoV ‐2
    Jun Liu, Yan Wu, George F. Gao · 2025 · Immunological Reviews
  68. No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
    Prerna Arora, Amy Madeleine Kempf, Inga Nehlmeier, Luise Graichen, Martin Sebastian Winkler, Martin Lier, Sebastian R. Schulz, Hans‐Martin Jäck, Stefan Pöhlmann, Markus Hoffmann · 2022 · Cellular and Molecular Immunology
  69. Standardized two-step testing of antibody activity in COVID-19 convalescent plasma
    P. Gilchuk, I. Thomsen, Sandra Yoder, Eric J. Brady, J. Chappell, Laura J. Stevens, M. Denison, Rachel E. Sutton, Rita E. Chen, Laura A. VanBlargan et al. · 2021 · iScience
  70. Leveraging South African HIV research to define SARS‐CoV ‐2 immunity triggered by sequential variants of concern
    Jinal N. Bhiman, Penny L. Moore · 2022 · Immunological Reviews
  71. Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection
    Mohammad A. I. Al-Hatamleh, Mai Abdel Haleem Abusalah, Ma’mon M. Hatmal, Walhan Alshaer, Suhana Ahmad, Manali Haniti Mohd-Zahid, Engku Nur Syafirah Engku Abd Rahman, Chan Yean Yean, Iskandar Zulkarnain Alias, Vuk Uskoković et al. · 2022 · Journal of Taibah University Medical Sciences
  72. Dynamical changes of SARS‐CoV ‐2 spike variants in the highly immunogenic regions impact the viral antibodies escaping
    Lorenzo Di Rienzo, Mattia Miotto, Fausta Desantis, Greta Grassmann, Giancarlo Ruocco, Edoardo Milanetti · 2023 · Proteins Structure Function and Bioinformatics
  73. Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core
    Pantelis Poumbourios, Christine Langer, Irene Boo, Tasnim Zakir, Anouschka Akerman, Vanessa Milogiannakis, Anupriya Aggarwal, Bronte A. Johnstone, Jungmin Ha, Fasséli Coulibaly et al. · 2023 · PLoS Pathogens
  74. The COVID-19 Pandemic: SARS-CoV-2 Structure, Infection, Transmission, Symptomology, and Variants of Concern
    Paul C. Guest, Prashant Kesharwani, Alexandra E. Butler, Amirhossein Sahebkar · 2023 · Advances in experimental medicine and biology
  75. Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1
    Alexander Muik, Jasmin Quandt, Bonny Gaby Lui, Maren Bacher, Sebastian Lutz, Maika Grünenthal, Aras Toker, Jessica Grosser, Orkun Ozhelvaci, Olga Blokhina et al. · 2024 · Cell Reports
  76. Identification of SARS-CoV-2 S RBD escape mutants using yeast screening and deep mutational scanning
    Cyrus M. Haas, Irené M. Francino-Urdaniz, Paul J. Steiner, Timothy A. Whitehead · 2021 · STAR Protocols
  77. Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera
    Marie‐Luise Herrlein, Sascha Hein, Tobias R. Zahn, Ines Mhedhbi, Jan Raupach, Younes Husria, Nuka Ivalu Benz, Jonathan Eisert, Daniela Bender, Vanessa Haberger et al. · 2022 · Viruses
  78. Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell–cell fusion, and neutralization sensitivity
    Li Zhang, Qianqian Li, Jiajing Wu, Yuanling Yu, Yue Zhang, Jianhui Nie, Ziteng Liang, Zhimin Cui, Shuo Liu, Haixin Wang et al. · 2022 · Emerging Microbes & Infections
  79. Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
    Alexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared Galloway, Megan A. O’Connor, Jesse H. Erasmus, Jennifer K. Logue, David W. Hawman, Helen Y. Chu, Kim J. Hasenkrug et al. · 2022 · PLoS Pathogens
  80. Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants
    Lili Li, Meiling Gao, Peng Jiao, Shulong Zu, Yong‐Qiang Deng, Dingyi Wan, Yang Cao, Jing Duan, Saba Roghiyh Aliyari, Jie Li et al. · 2022 · Cell & Bioscience
  81. Environmental Impacts on COVID-19: Mechanisms of Increased Susceptibility
    Stephania A. Cormier, Ayaho Yamamoto, Kirsty Renfree Short, Luan D. Vu, William A. Suk · 2022 · Annals of Global Health
  82. Prediction of antibody binding to SARS-CoV-2 RBDs
    Eric Ji Da Wang · 2022 · Bioinformatics Advances
  83. Comparative Characterization of Diverse DNA Aptamers for Recognition of Spike Proteins of Multiple SARS‐CoV‐2 Variants
    Zijie Zhang, Jiuxing Li, Ryan Amini, Alexandria Mansfield, Jimmy Gu, Jianrun Xia, John D. Brennan, Yingfu Li · 2023 · Analysis & Sensing
  84. Evidence of natural selection and dominance of SARS-CoV-2 variant Lambda (C.37) over variants of concern in Cusco, Peru
    María Antonieta Quispe-Ricalde, Hugo Gildardo Castelán-Sánchez, Pablo M. Meza-Rodríguez, Sonia Dávila‐Ramos, José Luis Sierra, Ramón Alberto Batista‐García, Fátima Concha-Velasco, Sonia Flores Lucana, José De Santa Cruz, Víctor Zea et al. · 2023 · Archives of Virology
  85. Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants
    Lidong Wang, Yang Wang, Hao Zhou · 2023 · International Journal of Biological Macromolecules
  86. AlphaFold2 Reveals Structural Patterns of Seasonal Haplotype Diversification in SARS-CoV-2 Spike Protein Variants
    Muhammad Asif Ali, Gustavo Caetano‐Anollés · 2024 · Biology
  87. Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
    Ruth I. Connor, Mrunal Sakharkar, Garrett Rappazzo, Chengzi I. Kaku, Nicholas C. Curtis, Seungmin Shin, Wendy Wieland‐Alter, Jordan Wentworth, Daniel W. Mielcarz, Joshua A. Weiner et al. · 2024 · Pathogens and Immunity
  88. Amino acids 484 and 494 of SARS-CoV-2 spike are hotspots of immune evasion affecting antibody but not ACE2 binding
    Marta Alenquer, Filipe Ferreira, Diana Lousa, Mariana Valério, Mónica Medina-Lopes, Marie‐Louise Bergman, Juliana Gonçalves, Jocelyne Demengeot, Ricardo B. Leite, Jingtao Lilue et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Human primary Omicron BA.1 and BA.2 infections result in sub-lineage-specific neutralization
    Karin Stiasny, Iris Medits, David Niklas Springer, Marianne Graninger, Jeremy Vann Camp, Eva Höltl, Stephan Walter Aberle, Marianna Theresia Traugott, Wolfgang Hoepler, Josef Deutsch et al. · 2022 · Research Square
  90. Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses
    Siyuan Sun, Jiaying He, Luotian Liu, Yuzhen Zhu, Qingsong Zhang, Yinong Qiu, Yuru Han, Song Xue, Xiaofang Peng, Yiming Long et al. · 2025 · Frontiers in Immunology
  91. Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection
    Rui Qiao, Jiayan Li, Jiami Gong, Yuchen Shao, Jizhen Yu, Yumeng Chen, Yinying Lu, Luxuan Yang, Luanfeng Lin, Zixin Hu et al. · 2025 · Vaccines
  92. From single-sequences to evolutionary trajectories: protein language models capture the evolutionary potential of SARS-CoV-2
    Kieran D. Lamb, J. Hughes, S. Lytras, Francesca Young, Orges Koci, James C. Herzig, S. Lovell, Joe Grove, Ke Yuan, D. L. Robertson · 2026 · Nature Communications
  93. Homologous and heterologous serological response to the N‐terminal domain of SARS‐CoV‐2 in humans and mice
    Huibin Lv, O. Tsang, Ray T. Y. So, Yi-Quan Wang, M. Yuan, Hejun Liu, Garrick K. Yip, Q. Teo, Yihan Lin, Wei-Wen Liang et al. · 2021 · European Journal of Immunology
  94. Evolution of SARS-CoV-2 during the first year of the COVID-19 pandemic in Northwestern Argentina
    Romina Zambrana Montaño, Andrés Carlos Alberto Culasso, Franco Daniel Fernández, Nathalie Marquez, Humberto Debat, Mariana Salmerón, Ana María Zamora, Gustavo Ruíz de Huidobro, Dardo Costas, Graciela Alabarse et al. · 2022 · Virus Research
  95. SARS-CoV-2 S Glycoprotein Stabilization Strategies
    Borys Pedenko, Guidenn Sulbarán, Delphine Guilligay, Grégory Effantin, Winfríed Weissenhorn · 2023 · Viruses
  96. A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
    Nicholas P. Wayham, Ariel R. Niedecken, Jan Fredrik Simons, Yao Chiang, Angélica V. Medina‐Cucurella, Rena A. Mizrahi, Ellen K. Wagner, Ashley Gras, Ilana Segal, Peyton Witte et al. · 2023 · The Journal of Infectious Diseases
  97. Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti–SARS-CoV-2 antibodies in the absence of CXCL13
    Marne Azarias-da-Silva, Pierre Nioche, Calaiselvy Soudaramourty, Anne Bull-Maurer, Mounira Tiouajni, Dechuan Kong, Ouafa Zghidi‐Abouzid, Morgane Picard, Ana Mendes‐Frias, André Santa Cruz et al. · 2023 · Science Advances
  98. High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
    William Bolland, Vincent Michel, Delphine Planas, Mathieu Hubert, Florence Guivel‐Benhassine, Françoise Porrot, Isabelle Staropoli, Mélissa N’Debi, Christophe Rodriguez, Slim Fourati et al. · 2023 · Journal of Virology
  99. Emergence of Novel SARS-CoV-2 variants in India: second wave
    Rama Adiga, Varun R Nayak · 2021 · The Journal of Infection in Developing Countries
  100. Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines
    Cong Sun, Runyu Yuan, Chu Xie, Jiufeng Sun, Xin‐Yan Fang, Yisha Hu, Xiaohui Yu, Zheng Liu, Mu‐Sheng Zeng, Yinfeng Kang · 2022 · Journal of Virology